日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Outcomes in Vitrectomized versus Non-vitrectomized Eyes in Patients with Primary Vitreoretinal Lymphoma

原发性玻璃体视网膜淋巴瘤患者行玻璃体切除术与未行玻璃体切除术的临床结果

Liberman, Paulina; Francis, Jasmine H; Mehrotra, Karnika; Tian, Jing; McGarrey, Mark P; Sobol, Ethan K; Thorne, Jennifer E; Aronow, Mary E; Berkenstock, Meghan K

Primary central nervous system lymphoma: Inter-compartmental progression

原发性中枢神经系统淋巴瘤:区室间进展

Raval, Vishal; Binkley, Elaine; Aronow, Mary E; Valenzuela, Juan; Peereboom, David M; Wei, Wei; Srivastava, Sunil; Davanzo, Jaqueline; Boldt, Herbert Culver; McGarrey, Mark P; Papaliodis, George N; Sobrin, Lucia; Kim, Ivana K; Vavvas, Dimitrios G; Eliott, Dean; Nayak, Lakshmi; Dodds, Emilio; Marco Del Pont, Francisco; Singh, Arun D

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals

葡萄膜黑色素瘤患者接受斑块放射治疗和预防性玻璃体内注射贝伐单抗(每 4 个月一次,持续 2 年)4 年后的视觉结果:与非随机历史对照个体的比较

Shields, Carol L; Dalvin, Lauren A; Chang, Michael; Mazloumi, Mehdi; Fortin, Patricia; McGarrey, Mark; Martin, Andrei; Yaghy, Antonio; Yang, Xiaolu; Vichitvejpaisal, Pornpattana; Mashayekhi, Arman; Shields, Jerry A

Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin

葡萄膜转移:基于原发肿瘤来源的1111例患者2214个肿瘤的临床特征和生存结局

Shields, Carol L; Welch, R Joel; Malik, Kunal; Acaba-Berrocal, Luis A; Selzer, Evan B; Newman, Jennifer H; Mayro, Eileen L; Constantinescu, Alexandru B; Spencer, Meredith A; McGarrey, Mark P; Knapp, Austen N; Graf, Alexander E; Altman, Alex J; Considine, Sean P; Shields, Jerry A